New Addition Ties Spherix’s Unique Approach to Syndicated Research to a Highly Dynamic Market, Filling White Space for Ophthalmology Pharmaceutical Players
EXTON, Pennsylvania., November 11, 2021 / PRNewswire / – Spherix Global Insights is a recognized market intelligence company providing independent coverage of select specialty markets. This week, the company officially cut the ribbon on its new franchise, ophthalmology.
Unlike other companies that offer syndicated reporting, Spherix derives actionable insights from its frequent, trade-focused primary market research that is highly personalized to each client’s unique needs. Having unparalleled content expertise and working with a network of highly engaged specialists are essentials that set Spherix apart in the business analytics and intelligence arena.
After careful review and at the request of several stakeholders, Spherix now covers key indications in ophthalmology including age-related neovascular macular degeneration, diabetic macular edema, diabetic retinopathy and other areas of emerging disease. . This new coverage comes at a particularly opportune time to market, as a range of new products (including the first biosimilar in ophthalmology) is about to be marketed in the short term.
Prior to the expansion, Spherix assembled a team of experts and performed a market landscape due diligence to bring the same value known by current customers to future partnerships within the space. The firm is proud to announce Ferguson Crystal as the Ophthalmology Knowledge Manager (formerly Director of Cross-Specialty Knowledge at Spherix), given her extensive experience in the field of therapy and the excellence of her previous role at Spherix.
“I am extremely excited to combine Spherix’s unique approach to market analysis and expert paneling with my over 10 years of ophthalmology experience to provide our customers the confidence to make clear decisions for their brands in a changing and dynamic market.“Ferguson says.
A full list of 2022 publications covered by the Spherix Ophthalmic Suite can be found here, covering our launch tracking, patient audit and market landscape services.
Learn more about our services here.
Click here to download the full 2022 release plan.
About Spherix Global Insights
Spherix Global Insights is a hyper-focused market intelligence company that draws on our own independent data and expertise to provide strategic advice, so biopharmaceutical stakeholders make confident decisions. We specialize in certain dermatology, gastroenterology, nephrology, neurology, ophthalmology and rheumatology markets.
All company, brand, or product names in this document are trademarks of their respective holders.
For more information, contact:
Ferguson Crystal, Insights Director Ophthalmology
E-mail: [email protected]
View original content to download multimedia: https://www.prnewswire.com/news-releases/fueled-by-growing-demand-spherix-global-insights-introduces-ophthalmology-to-expert-suite-of-independent -market-research-and-intelligence-services-301422433.html
SOURCE Spherix Global Insights